Use cases

With the most robust behavioral health database of its kind and seamless AI-powered analytic tools, NeuroBlu enables uniquely powerful evidence generation. Explore the use cases below to discover how you can address key research questions to drive clinical and commercial success in behavioral health. To learn more, please contact us at info@neuroblu.ai.

CLINICAL DEVELOPMENT

Analyzing hospitalization rate, treatment switch, and effectiveness between two MDD drugs

Comparing fluoxetine and citalopram in relation to psychiatric hospitalizations and change in CGI-S.
April 29, 2022
VIEW
CLINICAL DEVELOPMENT

Comparing effectiveness of two medications by evaluating negative symptoms in patients diagnosed with schizophrenia

Leveraging Holmusk’s proprietary NLP algorithm to evaluate effectiveness of two drugs on schizophrenia patients.
April 1, 2022
VIEW
© 2020-2023 Holmusk
NeuroBlu Privacy Centre
Back to top
Contact us